Page last updated: 2024-11-06

gold cyanide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID68172
MeSH IDM0144417

Synonyms (12)

Synonym
gold cyanide
gold(i) cyanide, 99.9% trace metals basis
506-65-0
gold monocyanide
einecs 208-049-1
gold cyanide (au(cn))
unii-03i25jds1h
gold(i) cyanide
AKOS025295395
DTXSID1060136
mfcd00003437
gold(1+);cyanide

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" This suggests that the extent of modification of the protein in vivo may have an important influence on the transport and bioavailability of gold antiarthritic drugs."( A mass spectrometric investigation of the binding of gold antiarthritic agents and the metabolite [Au(CN)2]- to human serum albumin.
Beck, JL; Ralph, SF; Talib, J, 2006
)
0.33
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (41)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (4.88)18.7374
1990's10 (24.39)18.2507
2000's18 (43.90)29.6817
2010's9 (21.95)24.3611
2020's2 (4.88)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 107.32

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index107.32 (24.57)
Research Supply Index3.76 (2.92)
Research Growth Index5.09 (4.65)
Search Engine Demand Index191.13 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (107.32)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (4.76%)6.00%
Case Studies4 (9.52%)4.05%
Observational0 (0.00%)0.25%
Other36 (85.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]